2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a prototypic halogenated aromatic hydrocarbon (HAH), is known as one of the most potent toxicants. At least a part of its toxic effects appears to be derived from its ability to induce TNF-α production. However, the signaling pathway of TCDD that leads to TNF-α expression has not been elucidated. In this study, we investigated the signaling mechanism of TCDD-induced TNF-α expression in PMA-differentiated THP-1 macrophages. TCDD induced both mRNA and protein expression of TNF-α in a dose-and time-dependent manner. α-Naphthoflavone (NF), an aryl hydrocarbon receptor (AhR) inhibitor, prevented the TCDD-induced expression of TNF-α at both mRNA and protein levels. Genistein, a protein tyrosine kinase (PTK) inhibitor, and PD153035, an EGFR inhibitor, also blocked the increase of TNF-α expression by TCDD, indicating the role of EGFR in TCDD-induced TNF-α expression. On the other hand, PP2, a c-Src specific inhibitor, did not affect TCDD-induced TNF-α expression. EGFR phosphorylation was detected as early as 5 min after TCDD treatment. TCDD-induced EGFR activation was AhR-dependent since co-treatment with α-NF prevented it. ERK was found to be a downstream effector of EGFR activation in the signaling pathway leading to TNF-α production after TCDD stimulation. Activation of ERK was observed from 30 min after TCDD treatment. PD98059, an inhibitor of the MEK-ERK pathway, completely prevented the TNF-α mRNA and protein expression induced by TCDD, whereas inhibitors of JNK and p38 MAPK had no effect. PD153035, an EGFR inhibitor, as well as α-NF significantly reduced ERK phosphorylation, suggesting that ERK activation by TCDD was mediated by both EGFR and AhR. These results indicate that TNF-α production by TCDD in differentiated THP-1 macrophages is AhR-dependent and involves activation of EGFR and ERK, but not c-Src, JNK, nor p38 MAPK. A signaling pathway is proposed where TCDD induces sequential activation of AhR, EGFR and ERK, leading to the increased expression of TNF-α.
Introduction
is a prototypic halogenated aromatic hydrocarbon and considered as the most potent toxicant in this family. It causes various species-and organ-specific toxic effects, including carcinogenicity, wasting, immune suppression, reproductive toxicity, teratogenecity and death (DeVito and Birnbaum, 1995) . The immune suppressive effect of TCDD includes both B and T cell responses. Reduced antibody responses have been shown in B lymphocytes exposed to TCDD (Dooley and Holsapple, 1988; Luster et al., 1988) , and in vivo studies indicate that cytotoxic and regulatory T cell functions may also be suppressed following TCDD exposure (Kerkvliet et al., 1990) . While TCDD treatment does not alter macrophge-mediated antigen presentation, phagocytosis or tumor cell cytolysis, there is evidence suggesting that TCDD stimulates production of inflammatory mediators such as reactive oxygen species and inflammatory cyto-kines (Clark et al., 1991; Alsharif et al., 1994) .
TNF-α is known as a primary mediator of an acute inflammatory response, and its over-production plays a key role in many pathologic processes (Vassalli, 1992) , including TCDD associated mortality, hypersensitivity to endotoxin, an enhanced peritoneal inflammatory response, cachexia, and endometriosis (Clark et al., 1991; Moos et al., 1994; Rier et al., 2001) . TCDD was reported to increase the serum TNF-α concentration in endotoxin-exposed mice (Clark et al., 1991) , and induce TNF-α production in peritoneal macrophages and Raw264.7 cells after LPS stimulation (Moos et al., 1997; Pestka and Zhou, 2006) .
TCDD enhanced inflammatory responses induced by intraperitoneal injection of sheep red blood cells into mice, and this hyper-inflammation was dramatically reduced by a soluble TNF-α receptor (Moos et al., 1994) . Furthermore, anti-TNF-α antibodies or dexamethasone reduced TCDDmediated mortality (Taylor et al., 1992) , indicating that the TNF-α-mediated inflammatory response contributed to the TCDD toxicity. However, the mechanism or the signaling pathway by which TCDD enhances TNF-α production has not been clearly understood.
Most, but not all, of the biological effects of TCDD are mediated by binding to its intracellular receptor, aryl hydrocarbon receptor (AhR). AhR is a ligand-activated transcription factor belonging to a basic-helix-loop-helix (bHLH)/Per-ARNT-Sim (PAS) family (Schmidt and Bradfield, 1996) . At a resting state, AhR exists in the cytoplasm as an inactive complex with a chaperone, heat shock protein 90, X-associated protein 2, and cochaperone protein, p23 (Whitelaw et al., 1993; Ma and Whitlock, 1997; Kazlauskas et al., 1999) . When TCDD binds to the cytoplasmic AhR, AhR is released from the complex and translocates to the nucleus. In the nucleus, AhR associates with its dimerization partner, AhR nuclear translocator (ARNT), and interacts with xenobiotic responsive elements (XREs). XREs, also known as dioxin responsive elements, are present in genes such as phase I and II detoxification genes (Schmidt and Bradfield, 1996) . In addition to its activity as a transcription factor, the ligand binding to AhR also triggers signal transduction pathways. However, this receptor-based model cannot explain all the biological effects of TCDD, and AhR-independent effects of TCDD have also been reported (Hossain et al., 1998; Ahmed et al., 2005) .
Signaling pathways triggered by TCDD are diverse and largely uncharacterized. Limited information indicates that the ability of TCDD to modulate protein kinase activity plays an important role in the TCDD-induced toxicity (Bombick et al., 1985 Madhukar et al., 1988; Matsumura, 1994) . TCDD immediately activates PKC and protein tyrosine kinase (PTK), such as EGFR and c-Src, in hepatocytes. It is not clear how EGFR is activated by TCDD stimulation, however, cross-talk between AhR and EGFR signaling pathways seems to play a role in hepatocarcinogenecity and the developmental toxicity induced by TCDD. c-Src is shown to be activated by TCDD in experimental animals, and the activation of c-Src contributes to the toxicity of TCDD (Enan et al., 1998a) . Park et al. (2005) also reported that TCDD activated ERK and p38 in a mouse macrophage cell line, Raw 264.7.
Despite the scattered information on the TCDDtriggered signaling mechanism and the knowledge of the molecular pathways by which the TNF-α expression is induced by LPS and other stimuli, the signaling mechanism of the TCDD-induced TNF-α expression remains unknown. In the present study, we investigated the signaling pathway involved in TCDD-induced TNF-α production in differentiated human THP-1 macrophages. Our data indicate that TNF-α production induced by TCDD results from AhR-dependent activation of EGFR and ERK, but c-Src, JNK or p38 MAPK is not involved.
Materials and Methods

Chemicals
LPS, PMA and actinomycin D were purchased from Sigma (St. Louis, MO). TCDD was purchased from Cerilliant Co. (Round Rock, TX).
Cell culture and differentiation
THP-1, a human promonocytic leukemia cell line and the Raw 264.7 mouse macrophage cell line were obtained from the American Type Culture Collection (Massas, VA) and the Korea Cell Line Bank (Seoul, Korea), respectively. Cells were maintained in RPMI-1640 (Cambrex Bio Science, Walkersville, MD) supplemented with 10% FBS, and antibiotics (100 µg/ml streptomycin, 100 U/ml penicillin G, and 0.25 µg/ml amphotericin B). Culture medium was tested for endotoxin contamination by Limulus Ameboecyte Lysate gel clot end point assay (Endosafe TM , Charles River laboratories, Charleston, SC), and negative for the endotoxin. The calculated value of 0.25 EU/ml was considered to be the threshold for endotoxin positivity. THP-1 cells were differentiated into macrophages by culturing with 150 nM PMA for 2 days.
Bioassay of TNF-α
The TNF-α protein concentration was calculated using a TNF-α-sensitive mouse fibroblast cell line, L929. Briefly, L929 cells were plated at a density of 7.5 × 10 3 cells/150 µl/well on a 96-well plate and incubated overnight in the RPMI-1640 medium supplemented with 10% FBS and antibiotics. On the next day, the medium was discarded, and 50 µl of new medium containing 2 µg/ml actinomycine D and 50 µl of the THP-1 culture supernatant were added. A standard curve was obtained using the recombinant TNF-α in a range of 0.25-500 pg/ml concentrations. The culture medium was discarded after incubation for 18 h at 37 o C, and 50 µl of 0.05% crystal violet in 20% ethanol was added. After incubation for 10 min at room temperature, the wells were thoroughly rinsed with tap water, and dried. Absorbance at 595 nm was measured with a microplate reader (Model 550, Bio-Rad, Hercules, CA) after adding 100 µl of 100% methanol to each well.
SYBR green real time PCR
For quantitative analysis of mRNA expression, the total RNA was extracted, and cDNA was synthesized by reverse transcription with Moloney murine leukemia virus (MMLV) reverse transcriptase and an oligo (dT) primer. Real time PCR was performed in a SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) containing SYBR Green 1 Dye, AmpliTaq Gold Ⓡ DNA Polymerase, dNTPs with dUTP, and optimized buffer components. Initial denaturation at 95 o C for 10 min and 40 cycles of 95 o C for 15 s and 60 o C for 1 min were carried out using the GeneAmp 7000 Sequence Detection System (Applied Biosystems). The sequences of primers were as follow; TNF-α, 5'-GCCAGAGGGCTGATTAGAGA-3' and 5'-TC-TTCTGCCTGCTGCACTT-3'; IL-1β, 5'-GGACAA-GCTGAGGAAGATGC-3' and 5'-TCGTTATCCCA-TGTGTCGAA-3'; IL-8, 5'-CTGCGCCAACACAGA-AATTA-3' and 5'-CTCTGCACCCAGTTTTCCTT-3'; GAPDH, 5'-AAGGTGAAGGTCGGAGTCAACG-3' and 5'-CCTTCTCCATGGTGGTGAAGAC-3'. The amount of mRNA of the target gene was normalized to that of GAPDH using the ∆Ct method, as described in the manufacturer's protocol.
Western blot analysis
Cells were lysed in 1× sample loading buffer (31.25 mM Tris-HCl, pH 6.8, 10% glycerol, 1% SDS, 2.5% β-mercaptoethanol) and boiled for 10 min. Protein concentrations of the lysates were measured using Coomassie Plus protein assay reagent (Pierce, Rockford, IL). Cell lysates were subjected to SDS-PAGE, and transferred onto a nitrocellulose membrane. The membrane was blocked in 5% skim milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 1 h, and incubated sequentially with a primary antibody for 1.5 h, and a HRP-conjugated secondary antibody for 1 h. The protein band of interest was detected using the Western Blot Luminol Reagent (Santa Cruz biotechnology Inc. Santa Cruz, CA). The primary antibodies for phospho-ERK and ERK were purchased from Cell Signaling Technology Inc. (Danvers, MA) and Santa Cruz Technology Inc. (Santa Cruz, CA), respectively.
Results
TCDD increases expression and secretion of TNF-α in differentiated THP-1 macrophages
The effect of TCDD on TNF-α expression was investigated in differentiated human THP-1 macrophages. The human monocytic THP-1 cells were treated with PMA (150 nM) for 2 days to differentiate them into macrophages and exposed to various concentrations (12.5-100 nM) of TCDD. After 24 h of TCDD treatment, the level of the secreted TNF-α protein in the culture supernatant was measured by L929 bioassay. The TNF-α production by TCDD was increased in a dosedependent manner up to 75 nM ( Figure 1A ). At 75 nM of TCDD, the TNF-α level in the culture supernatant increased by 2-fold. Figure 1B shows temporal analysis of TNF-α mRNA expression assessed by real-time PCR. The level of TNF-α mRNA continuously increased up to 20 h after exposure to TCDD: At that time, the mRNA expression of TNF-α in the TCDD-treated cells was elevated by 4.1 fold compared to that in DMSOtreated control cells. These results show that TCDD induced both mRNA and protein expression of TNF-α in differentiated THP-1 macrophages. TCDD did not induce TNF-α expression in undifferentiated monocytic THP-1 cells at the same concentrations (data not shown).
TCDD also augmented the level of IL-8 mRNA expression by 2.7 fold, but did not significantly affect the IL-1β mRNA expression ( Figure 1C) . In contrast to the PMA-differentiated THP-1 human macrophages, Raw 264.7 murine macrophage cells, did not increase TNF-α expression after stimulation with TCDD alone. In Raw 264.7 cells, TNF-α could be induced by co-treating LPS along with TCDD ( Figure 1D ). 
AhR mediates up-regulation of TNF-α expression by TCDD
As a first step to elucidate the signaling pathway through which TCDD induced TNF-α expression, we investigated whether the increased TNF-α expression by TCDD was an AhR-dependent effect. Although AhR is a receptor for TCDD, AhR-independent effects of TCDD have also been reported (Hossain et al., 1998; Ahmed et al., 2005) . Differentiated THP-1 macrophages were treated with α-naphthoflavone (α-NF), an AhR antagonist, together with TCDD. As shown in Figure 2 , α-NF prevented up-regulation of the TNF-α expression induced by TCDD in a dose-dependent manner. The TCDD-induced TNF-α expression was completely inhibited by 1 µM α-NF at both mRNA and protein levels. These results suggest that AhR mediates the TCDD-induced TNF-α expression in differentiated THP-1 macrophages. 
EGFR activation is required for TCDD-induced TNF-α expression
Since protein tyrosine kinases (PTKs) were implicated in the cellular responses to TCDD, the role of PTK in the up-regulation of TNF-α expression after TCDD treatment was investigated. Figure 3 shows that genistein, a broad spectrum PTK inhibitor, blocked the TCDD-induced TNF-α expression in a dose-dependent manner. Genistein at a 50 µg/ml concentration completely inhibited the increase of TNF-α expression induced by TCDD at both mRNA and protein levels.
Therefore, we searched for the PTK that participated in the TCDD-induced signaling which led to the up-regulation of TNF-α expression. Roles of EGFR and c-Src, the two known TCDD-activated PTKs, were examined using chemical inhibitors. Pretreatment of the THP-1 macrophages with an EGFR inhibitor, PD153035, suppressed the TCDDinduced expression of TNF-α mRNA and protein ( Figure 4A and B) . The inhibition of TCDD-induced TNF-α expression by PD153035 was dose-dependant, and at 50 nM, the inhibition was complete. Next, EGFR activation by TCDD was investigated by an immunoblot analysis. Immunoprecipitation of EGFR followed by immunoblotting with an anti-phospho-EGFR antibody shows that EGFR is activated as early as 5 min after TCDD treatment ( Figure 4C ). The rapid kinetics suggest that EGFR activation constitutes an upstream event in the TCDD-induced signaling. On the other hand, a c-Src specific inhibitor, PP2, did not affect TCDDinduced TNF-α expression at concentrations up to 1 µM, suggesting that c-Src activity was not required in TCDD-induced TNF-α expression ( Figure 4D ). Even higher concentrations of PP2 (up to 10 µM) failed to suppress the effect of TCDD on TNF-α expression (data not shown). Altogether, these results indicate that EGFR, but not c-Src, is involved in TCDD-induced TNF-α expression in differentiated THP-1 macrophages. 
ERK is involved in TCDD-induced up-regulation of TNF-α expression
ERK is one of the major downstream effector molecules of EGFR and shown to be activated by AhR stimulation in Raw 264.7 mouse macrophage cells (Park et al., 2005) . Therefore, we investigated whether ERK was activated in response to TCDD treatment and whether it was required for TCDDinduced TNF-α expression. ERK activation was assessed by an immunoblot analysis using phospho-ERK specific antibody. Upon TCDD treatment, ERK was activated within 30 min ( Figure 5A , upper panel), and the activation was sustained for 6 h. The ERK protein level was not changed by TCDD treatment ( Figure 5A, lower panel) . Increased ERK activation by TCDD was indeed mediated by EGFR, since inhibition of EGFR activity using a chemical inhibitor, PD153035 completely suppressed TCDD-induced ERK phosphorylation ( Figure   5B ). The ERK activity was found to be required for the TCDD-induced TNF-α expression. PD98059, an inhibitor of the MEK-ERK pathway, prevented TCDD-induced expression of TNF-α mRNA and protein ( Figure 5C and D) : The inhibition by PD98059 was dose-dependent with complete inhibition at 50 µM. However, other MAPK inhibitors such as a JNK inhibitor, SP600125, and a p38 MAPK inhibitor, SB203580, did not affect TCDDinduced TNF-α expression, and the evidence of p38 or JNK activation was not found in an immunoblot analysis (data not shown).
Activation of EGFR and ERK by TCDD is AhR-dependent
To investigate whether activation of the EGFR-ERK pathway following TCDD sitmulation depended on AhR, the effect of α-NF on EGFR and ERK activation was assessed. Differentiated THP-1 cells were co-treated with α-NF and TCDD, and after 5 min, EGFR was immunoprecipitated for an immunoblot analysis of EGFR phosphorylation. As shown in Figure 6A , α-NF at 1 µ M completely blocked EGFR phosphorylation, suggesting that EGFR phosphorylation by TCDD requires AhR activation. Similarly, in accordance with the finding that EGFR mediated ERK activation after TCDD treatment, ERK activation by TCDD was significantly reduced by co-treatment of α-NF. These results provide evidence that AhR mediates EGFR-ERK activation by TCDD.
Discussion
TNF-α was shown to be induced upon exposure to TCDD (Clark et al., 1991; Moos et al., 1997; Zeytun et al., 2002; Wu et al., 2004) and implicated in TCDD toxicity such as mortality, hypersensitivity to endotoxin, enhanced peritoneal inflammatory response, cachexia, and endometriosis (Clark et al., 1991; Moos et al,, 1994; Rier et al., 2001) . However, most of the previous studies were based on a mouse model, and the detailed mechanism by which TCDD induces TNF-α production has not been clearly understood.
In the present study, it was shown that α-NF, an AhR antagonist, completely prevented TNF-α expression mediated by TCDD, suggesting that AhR mediated it. This result is in contrast to benzo(a)-pyrene-induced TNF-α secretion which was AhRindependent (Lecureur et al., 2005) . In general, the ligand-activated AhR mediates the effect of TCDD by interacting with XRE in the 5'-flanking regions of target genes. However, AhR-regulated XREs have not been found in the 5'-flanking region of the human TNF-α gene (Sun et al., 2004) . Therefore, it appears that other signaling pathway is involved rather than the ligand-activated AhR directly activates transcription of the TNF-α gene.
It has been reported that TCDD rapidly activates PKC and PTK in hepatocyte membranes (Bombick et al., 1985 Matsumura, 1994) . The EGFR tyrosine kinase is known to be activated by TCDD and involved in TCDD-induced pathogenesis of liver and adipose tissues (Madhukar et al., 1988; Matsumura, 1994) . In this study, it was found that EGFR was also involved in TCDD-induced TNF-α expression in THP-1 macrophages. TCDD is not an EGFR ligand, and the TCDD-induced EGFR activation was mostly explained by an autocrine loop produced by a TCDD-induced expression and secretion of TGF-α and EGF (Gaido et al., 1992; Davis et al., 2003) . Although the exact mechanism of EGFR activation in TCDD-induced TNF-α expression needs to be elucidated, our results show that EGFR activation occurs rapidly (within 5 min) after TCDD stimulation and is mediated by AhR.
Functionally relevant EGFR activation should lead to an increase in ERK activation by phosphorylation. ERK phosphorylation in response to TCDD has been demonstrated in primary cultures of endocervical epithelium of macaque, and in Jurkat and mouse hepatoma cells (Enan et al., 1998b; Tan et al., 2002; Kwon et al., 2003) . Our data showed that activation of ERK was required in TNF-α expression triggered by TCDD: Phosphorylation of ERK in differentiated THP-1 macrophages was induced within 30 min of TCDD treatment, and PD98059, an inhibitor of the MEK-ERK pathway, abolished TCDD-induced TNF-α expression. Increased ERK phophorylation by TCDD was abolished by an EGFR inhibitor, PD153035, indicating that TCDD-induced ERK activation is indeed mediated by EGFR. The RAS-RAF-MEK signaling pathway might mediate the ERK activation by EGFR tyrosine kinase . Alternatively, signaling molecules downstream of EGFR, such as PKC, PLC-γ and PI3K, which are known to be involved in the induction of ERK activity by various stimuli, might be responsible for the TCDD-induced ERK activation . Although c-Src activation by TCDD has been reported (Madhukar et al., 1988) , and ERK activation can be induced by c-Src, it does not appear to be involved in TNF-α expression induced by TCDD. PP2, a specific inhibitor of the Src-family kinases, did not prevent TCDD-induced TNF-α expression ( Figure 4C ).
Although NF-κB is a well-known transcription factor activating TNF-α gene transcription, it does not seem to mediate the induction of TNF-α expression in TCDD-treated THP-1 macrophages. TCDD failed to increase DNA binding activity of NF-κB (data not shown). In this line, exposure of human macrophages to benzo(a)pyrene also induced TNF-α expression without enhancing NF-κB DNA binding activity (Lecureur et al., 2005) . TCDD did not activate NF-κB in mouse models as well (Suh et al., 2002; Patterson et al., 2003) , and even suppressed TNF-α-and anti-CD40-induced NF-κB activation in dendritic cells (Ruby et al., 2002) . We also failed to observe the increased DNA binding activity of AP-1 by TCDD despite of ERK activation (data not shown).
In differentiated human THP-1 macrophages, TCDD increased both TNF-α mRNA expression and secretion of TNF-α protein in the absence of LPS. In contrast, in a murine macrophage cell line, Raw 264.7, TNF-α could only be induced by TCDD in the presence of LPS ( Figure 1D ). The requirement of LPS in TCDD-induced TNF-α secretion has also been shown in mouse peritoneal macrophages (Moos et al., 1997; Pestka and Zhou, 2006) . Likewise, benzo(a)pyrene did not induce TNF-α secretion in Raw 264.7 cells, but benzo(a)-pyrene plus carbon black caused release of TNF-α (Chin et al., 1998) . The difference might be explained by a species-specific difference in the effect of TCDD on TNF-α induction. Another possibility is that the TNF-α production from macrophages requires pre-sensitization with LPS or other mitogenic signals before or along with the exposure to TCDD. In this case, PMA treated to differentiate the human promonocytic THP-1 cells prior to the TCDD exposure might have provided the necessary pre-sensitization as LPS might have done to mouse macrophages.
In summary, we found that TCDD enhanced TNF-α production in differentiated human THP-1 macrophages, and AhR, EGFR, and ERK participated in the TCDD-triggered signaling pathway leading to the increased TNF-α expression. Based on the evidence provided in this study, a signaling pathway for the TCDD-induced TNF-α expression is proposed that TCDD binds AhR which then activates the EGFR-ERK pathway through which expression of the TNF-α gene is up-regulated. Although the involvement of EGFR and ERK in TCDD-induced carcinogenesis was reported in many cases, it has not been known that they also play roles in TCDD-induced TNF-α expression. This pathway is distinct from that of LPS-or IL-1-induced TNF-α expression mediated by NF-κB. These results provide better understanding for the TCDD toxicity mediated by TNF-α.
